Kalich Ronald B Sr's Form 4 filing
Surmodics Inc (SRDX) · filed Nov 15, 2022
- Accession no.
- 0001209191-22-057002
- Filed
- Nov 15, 2022
- Trade date
- Nov 11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $91.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kalich Ronald B SrCIK 0001198349 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2022 | Common Stock | MOption exerciseAcquired | +4,366 | $20.18 | +$88,105.88 | 32,912 | Direct | |
| Nov 11, 2022 | Common Stock | SSaleDisposed | −2,733 | $33.48F1 | −$91,500.84 | 30,179 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2022 | Common Stock | MOption exerciseDisposed | −4,366 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average price of 2,733 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 11, 2022 with sale prices ranging from $33.40 to $33.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.